Amplified in breast cancer-1 glutamine repeat and prostate cancer risk

Prostate Journal

Volumn 2, Issue 1, 2000, Pages 27-32

  Platz, Elizabeth A ^a,d   Giovannucci, Edward ^a,b   Brown, Myles ^c   Cieluch, Carsta ^c   Shepard, Timothy F ^c   Stampfer, Meir J ^a,b   Kantoff, Philip W ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMINE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER RISK; GENE AMPLIFICATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

EID: 0033966382     PISSN: 10955100     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1411.2000.15005.x     Document Type: Article

References (13)

1. Anzick SL, Kononen J, Walker RL, et al. (1997) AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science 277: 965-968.
2. Bautista S, Valles H, Walker RL, et al. (1998) In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res. 4: 2925-2929.
3. Xu L, Glass CK, Rosenfeld MG. (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9: 140-147.
4. Shirazi SK, Bober MA, Coetzee GA. (1998) Polymorphic exonic CAG microsatellites in the gene amplified in breast cancer (AIB1 gene). Clin. Genet. 54: 102-103.
5. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. (1996) Prospective study of sex hormone levels and risk of prostate cancer. J. Natl. Cancer Inst. 88: 1118-1126.
6. Rebbeck T, Kantoff P, Krithivas K, et al. (1999) Modification of breast cancer risk in BRCA1 mutation carriers by the AIB1 gene. Proc. Am. Assoc. Cancer Res. Annu. Meet. 40: 194.
7. Steering Committee of the Physicians' Health Study Research Group. (1989) Final report on the aspirin component of the ongoing Physicians' Health Study. N. Engl. J. Med. 321: 129-135.
8. Catalona WJ, Avioli LV. (1987) Diagnosis, staging, and surgical treatment of prostatic carcinoma. Arch. Intern. Med. 147: 361-363.
9. Gittes RF. (1991) Carcinoma of the prostate. N. Engl. J. Med. 324: 236-245.
10. Giovannucci E, Stampfer MJ, Krithivas K, et al. (1997) The CAG repeat within the androgen receptor gene and its relationship to prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 94: 3320-3323.
11. Rosner B. (1986) Fundamentals of Biostatistics. 2nd ed. Duxbury Press, Boston, MA.
12. Kleinbaum DG, Kupper LL, Morgenstern H. (1982) Epidemiologic Research: Principles and Quantitative Methods. Van Nostrand Reinhold, New York.
13. Coffey DS. (1979) Physiological control of prostatic growth: an overview. Prostate Cancer. UICC Technical Report Series. International Union Against Cancer, Geneva, Switzerland, pp. 4-23.